Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.53 (
sialidase
)
2,694
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Protein kinase A
(
PKA
) has been suggested as a regulator of stage differentiation in Trypanosoma cruzi. Using a yeast two-hybrid system we have begun to characterize the downstream substrates of T. cruzi
PKA
. We identified several members of the trans-
sialidase
super family by this approach. Immunoprecitation demonstrated that a TcPKAc monoclonal antibody was able to pull-down proteins recognized by trans-
sialidase
antibodies as well as a SA85-1.1 antibody and vice versa. An in vitro phosphorylation assay demonstrated that
PKA
phosphorylated the recombinant protein of an active trans-
sialidase
. In addition, a phospho-(Ser/Thr)
PKA
substrate antibody detected bands on immunoblot analysis of trans-
sialidase
antibody precipitated proteins from parasite lysate and the media of L(6)E(9) myoblasts infected with trypomastigotes as well as from a SA85-1.1 antibody precipitated proteins from parasite lysate. Immunofluorescence analysis suggested that some TcPKAc localizes to the plasma membrane surface of trypomastigotes. The identified trans-sialidases have
PKA
consensus phosphorylation sites located near the endoplasmic reticulum retention motif in the N-terminal. These data support that
PKA
phosphorylates trans-
sialidase
super family members in vivo.
...
PMID:Protein kinase A catalytic subunit interacts and phosphorylates members of trans-sialidase super-family in Trypanosoma cruzi. 2046 66